A Multi Center, Open Label, Single-Arm Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP), Including the Pustular Form (PsPPP).
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms TIPS
- Sponsors Schering-Plough
- 23 Jun 2010 Trial phase changed from IV to III as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2008 Planned end date changed from 1 Oct 2008 to 1 Mar 2009 as reported by ClinicalTrials.gov.